Niagen Bioscience Inc
General ticker "NAGE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $650.1M (TTM average)
Niagen Bioscience Inc follows the US Stock Market performance with the rate: 24.1%.
Estimated limits based on current volatility of 1.6%: low 6.44$, high 6.64$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.02$, 10.53$]
- 2025-12-31 to 2026-12-31 estimated range: [4.61$, 9.66$]
Financial Metrics affecting the NAGE estimates:
- Positive: with PPE of 126.4 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 7.76
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: Operating cash flow per share per price, % of 2.59 <= 6.82
- Negative: Shareholder equity ratio, % of 67.51 > 63.39
Short-term NAGE quotes
Long-term NAGE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $72.05MM | $83.57MM | $99.60MM |
| Operating Expenses | $90.68MM | $89.17MM | $91.87MM |
| Operating Income | $-18.63MM | $-5.60MM | $7.73MM |
| Non-Operating Income | $2.09MM | $0.66MM | $1.13MM |
| R&D Expense | $4.83MM | $4.96MM | $6.02MM |
| Income(Loss) | $-16.54MM | $-4.94MM | $8.86MM |
| Taxes | $0.00MM | $0.00MM | $0.30MM |
| Profit(Loss)* | $-16.54MM | $-4.94MM | $8.55MM |
| Stockholders Equity | $28.67MM | $28.46MM | $46.09MM |
| Inventory | $14.68MM | $14.53MM | $9.19MM |
| Assets | $54.06MM | $54.96MM | $68.28MM |
| Operating Cash Flow | $-15.10MM | $7.12MM | $12.11MM |
| Capital expenditure | $0.33MM | $0.15MM | $0.16MM |
| Investing Cash Flow | $-0.33MM | $-0.14MM | $-0.14MM |
| Financing Cash Flow | $7.65MM | $-0.09MM | $5.37MM |
| Earnings Per Share** | $-0.24 | $-0.07 | $0.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.